Trials / Completed
CompletedNCT03531372
Mipolixin® Compared to Poliprotect® in Moderate Functional Dyspepsia and Heartburn.
Efficacy and Safety of Mipolixin® Compared to Poliprotect ® in the Relief of Symptoms of Moderate Functional Dyspepsia and Heartburn: A Randomized, Double-blind, Parallel Group,Non-inferiority Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 158 (actual)
- Sponsor
- Aboca Spa Societa' Agricola · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the clinical efficacy of two medical devices, Mipolixin® and Poliprotect®, in improving the overall symptom severity of functional dyspesia and/or heartburn
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mipolixin® | 1.55g chewable tablet 5 times a day for 2 weeks |
| DEVICE | Poliprotect® | 1.55 g chewable tablet 5 times a day for 2 weeks |
Timeline
- Start date
- 2018-04-24
- Primary completion
- 2021-04-30
- Completion
- 2021-04-30
- First posted
- 2018-05-21
- Last updated
- 2021-05-26
Locations
11 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03531372. Inclusion in this directory is not an endorsement.